CytomX Therapeutics, Inc.
US ˙ NasdaqGS ˙ US23284F1057

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for McCarthy Sean A.. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at McCarthy Sean A. har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:CTMX / CytomX Therapeutics, Inc. CEO, Director 1.089.684
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af McCarthy Sean A.. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb CTMX / CytomX Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CTMX / CytomX Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CTMX / CytomX Therapeutics, Inc. Insider Trades
Insidersalg CTMX / CytomX Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CTMX / CytomX Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2025-06-16 CTMX McCarthy Sean A. 55.511 2,6889 55.511 2,6889 149.264 59 1.7600 -51.564 -34,55
2025-03-18 CTMX McCarthy Sean A. 37.656 0,5990 37.656 0,5990 22.556
2024-08-20 CTMX McCarthy Sean A. 13.898 1,2291 13.898 1,2291 17.082
2024-03-19 CTMX McCarthy Sean A. 20.223 2,0855 20.223 2,0855 42.175
2023-12-20 CTMX McCarthy Sean A. 13.551 1,3807 13.551 1,3807 18.710
2023-09-22 CTMX McCarthy Sean A. 14.601 1,3004 14.601 1,3004 18.987
2023-03-16 CTMX McCarthy Sean A. 7.121 1,8805 7.121 1,8805 13.391
2022-07-20 CTMX McCarthy Sean A. 14.911 1,4222 14.911 1,4222 21.206
2017-09-01 CTMX McCarthy Sean A. 368 17,5000 368 17,5000 6.440
2017-08-31 CTMX McCarthy Sean A. 9.194 17,5000 9.194 17,5000 160.895

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CTMX / CytomX Therapeutics, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af McCarthy Sean A. som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-06-17 2025-06-16 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale -55.511 1.089.684 -4,85 2,69 -149.264 2.930.051
2025-06-17 2025-06-13 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 150.000 1.145.195 15,07
2025-03-20 2025-03-18 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale -37.656 995.195 -3,65 0,60 -22.556 596.122
2025-02-06 2025-02-04 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 195.000 1.032.851 23,27
2025-02-06 2025-02-04 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 180.000 837.851 27,36
2024-08-22 2024-08-20 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale -13.898 657.851 -2,07 1,23 -17.082 808.565
2024-08-22 2024-08-20 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 37.500 671.749 5,91
2024-03-28 2024-03-26 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 109.768 634.249 20,93 1,57 172.874 998.879
2024-03-21 2024-03-19 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale -20.223 524.481 -3,71 2,09 -42.175 1.093.805
2024-01-19 2024-01-18 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 90.000 544.704 19,79
2023-12-22 2023-12-20 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale -13.551 454.704 -2,89 1,38 -18.710 627.810
2023-12-19 2023-12-17 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 37.500 468.255 8,71
2023-09-22 2023-09-22 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale -14.601 430.755 -3,28 1,30 -18.987 560.154
2023-09-22 2023-09-20 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 40.000 445.356 9,87
2023-05-23 2023-05-19 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 16.535 405.356 4,25 1,57 26.041 638.395
2023-03-20 2023-03-16 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale -7.121 388.821 -1,80 1,88 -13.391 731.178
2023-02-06 2023-02-02 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 105.000 395.942 36,09
2022-07-21 2022-07-20 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale -14.911 290.942 -4,88 1,42 -21.206 413.778
2022-07-21 2022-07-19 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 40.000 305.853 15,05
2022-05-11 2022-05-09 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -24.189 0 -100,00
2022-05-11 2022-05-09 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -66.742 0 -100,00
2022-05-11 2022-05-09 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 24.189 265.853 10,01 0,94 22.859 251.231
2022-05-11 2022-05-09 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 66.742 241.664 38,16 0,94 63.071 228.372
2022-02-04 2022-02-02 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 450.000 450.000
2022-02-04 2022-02-02 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 75.000 174.922 75,06
2021-10-26 2021-10-24 4 CTMX CytomX Therapeutics, Inc.
Performance Stock Units (PSUs)
A - Award 80.000 80.000
2021-10-26 2021-10-24 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 100.000 100.000
2021-08-13 2021-08-11 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -92.113 0 -100,00
2021-08-13 2021-08-11 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 92.113 99.922 1.179,57 1,13 104.447 113.302
2021-06-21 2021-06-16 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -100.000 93.118 -51,78 7,04 -704.470 655.988
2021-06-16 2021-06-14 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -10 66.742 -0,01
2021-06-16 2021-06-14 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -30 92.113 -0,03
2021-06-16 2021-06-14 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 10 7.849 0,13 0,94 9 7.417
2021-06-16 2021-06-14 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 30 7.839 0,38 1,13 34 8.889
2021-06-08 2019-09-30 4 CTMX CytomX Therapeutics, Inc.
Common Stock
G - Gift -4.500 7.809 -36,56
2021-04-02 2021-03-31 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -100.000 92.143 -52,04
2021-04-02 2021-03-31 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -100.000 206.894 -32,58 7,49 -749.470 1.550.608
2021-04-02 2021-03-31 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 100.000 306.894 48,33 1,13 113.390 347.987
2021-03-02 2021-02-27 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 200.000 200.000
2021-03-02 2021-02-26 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
A - Award 400.000 400.000
2020-12-28 2020-12-23 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -100.000 192.143 -34,23
2020-12-28 2020-12-23 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 100.000 206.894 93,55 1,13 113.390 234.597
2020-12-07 2020-11-30 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 930 106.894 0,88 6,39 5.945 683.266
2020-09-23 2020-09-21 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -20.500 0 -100,00
2020-09-23 2020-09-21 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 20.500 105.964 23,99 6,61 135.601 700.920
2020-06-02 2020-05-29 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 1.158 85.464 1,37 5,11 5.916 436.593
2020-05-14 2020-05-12 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -36.000 292.143 -10,97
2020-05-14 2020-05-12 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -36.000 84.306 -29,92 15,00 -540.000 1.264.590
2020-05-14 2020-05-12 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 36.000 120.306 42,70 1,13 40.820 136.415
2020-02-19 2020-02-14 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
A - Award 500.000 500.000
2019-12-16 2019-11-30 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 1.080 84.306 1,30 5,32 5.747 448.592
2019-06-04 2019-05-31 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 695 83.226 0,84 8,21 5.707 683.369
2019-01-29 2019-01-25 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
A - Award 300.000 300.000
2018-12-06 2018-11-30 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 468 82.531 0,57 11,73 5.490 968.089
2018-11-05 2018-11-02 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise X -1.156 136.071 -0,84
2018-11-05 2018-11-02 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -1.156 82.063 -1,39 15,01 -17.348 1.231.519
2018-11-05 2018-11-02 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise X 1.156 83.219 1,41 1,57 1.821 131.062
2018-11-05 2018-11-01 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise X -5.370 137.227 -3,77
2018-11-05 2018-11-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -5.270 82.063 -6,03 15,00 -79.050 1.230.945
2018-11-05 2018-11-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -100 87.333 -0,11 15,00 -1.500 1.310.432
2018-11-05 2018-11-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise X 5.370 87.433 6,54 1,57 8.457 137.698
2018-09-06 2018-09-04 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise X 13.052 142.597 10,08
2018-09-06 2018-09-04 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -13.052 82.063 -13,72 21,86 -285.343 1.794.061
2018-09-06 2018-09-04 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise X 13.052 95.115 15,90 1,57 20.556 149.797
2018-07-09 2018-07-05 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise X -4.497 155.649 -2,81
2018-07-09 2018-07-05 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -4.497 82.063 -5,20 25,06 -112.689 2.056.384
2018-07-09 2018-07-05 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise X 4.497 86.560 5,48 1,57 7.082 136.323
2018-07-06 2018-07-03 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise X -2.028 160.146 -1,25
2018-07-06 2018-07-03 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -2.028 82.063 -2,41 25,09 -50.880 2.058.879
2018-07-06 2018-07-03 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise X 2.028 84.091 2,47 1,57 3.194 132.435
2018-07-03 2018-07-02 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise X -13.052 162.174 -7,45
2018-07-03 2018-07-02 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -13.052 82.063 -13,72 23,42 -305.708 1.922.104
2018-07-03 2018-07-02 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise X 13.052 95.115 15,90 1,57 20.556 149.797
2018-06-05 2018-05-31 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 302 4.945 6,50 17,90 5.406 88.520
2018-05-02 2018-05-01 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise X -19.578 175.226 -10,05
2018-05-02 2018-05-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -19.578 4.643 -80,83 26,55 -519.743 123.259
2018-05-02 2018-05-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise X 19.578 24.221 421,67 1,57 30.833 38.146
2018-03-05 2018-03-01 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -62 66.752 -0,09
2018-03-05 2018-03-01 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -9.000 328.143 -2,67
2018-03-05 2018-03-01 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -10.516 194.804 -5,12
2018-03-05 2018-03-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -19.578 4.643 -80,83 29,43 -576.141 136.634
2018-03-05 2018-03-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 62 24.221 0,26 0,94 59 22.889
2018-03-05 2018-03-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 9.000 24.159 59,37 1,13 10.205 27.394
2018-03-05 2018-03-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 10.516 15.159 226,49 1,57 16.562 23.874
2018-02-12 2017-09-07 5 CTMX CytomX Therapeutics, Inc.
Common Stock
G - Gift -4.500 154.237 -2,83
2018-01-26 2018-01-24 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
A - Award 300.000 300.000
2018-01-09 2018-01-05 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -6.526 337.143 -1,90
2018-01-09 2018-01-05 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -6.526 4.643 -58,43 25,01 -163.215 116.121
2018-01-09 2018-01-05 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 6.526 11.169 140,56 1,13 7.400 12.665
2018-01-04 2018-01-02 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -13.052 343.669 -3,66
2018-01-04 2018-01-02 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -13.052 4.643 -73,76 21,04 -274.614 97.689
2018-01-04 2018-01-02 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 13.052 17.695 281,11 1,13 14.800 20.064
2017-12-05 2017-12-01 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -10.240 356.721 -2,79
2017-12-05 2017-12-01 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -4.100 115.193 -3,44
2017-12-05 2017-12-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -14.340 4.643 -75,54 20,60 -295.404 95.646
2017-12-05 2017-12-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 10.240 18.983 117,12 1,13 11.611 21.525
2017-12-05 2017-12-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 4.100 8.743 88,30 0,94 3.874 8.262
2017-12-05 2017-11-30 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 398 4.643 9,38 12,15 4.834 56.396
2017-11-03 2017-11-01 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -14.342 119.293 -10,73
2017-11-03 2017-11-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -14.342 4.245 -77,16 19,86 -284.832 84.306
2017-11-03 2017-11-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 14.342 18.587 337,86 0,94 13.553 17.565
2017-10-06 2017-10-04 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise -19.120 133.635 -12,52
2017-10-06 2017-10-04 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -19.120 4.245 -81,83 24,13 -461.366 102.432
2017-10-06 2017-10-04 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 19.120 23.365 450,41 0,94 18.068 22.080
2017-10-04 2017-10-02 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -9.562 15.481 -38,18
2017-10-04 2017-10-02 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -9.562 4.245 -69,25 18,57 -177.566 78.830
2017-10-04 2017-10-02 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 9.562 13.807 225,25 0,94 9.036 13.048
2017-09-22 2017-09-01 4/A CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -9.930 25.043 -28,39
2017-09-22 2017-09-01 4/A CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale -368 4.245 -7,98 17,50 -6.440 74.288
2017-09-22 2017-09-01 4/A CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -9.562 4.613 -67,46 17,32 -165.614 79.897
2017-09-22 2017-09-01 4/A CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 9.930 14.175 233,92 0,94 9.384 13.395
2017-09-22 2017-08-31 4/A CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -18.756 34.973 -34,91
2017-09-22 2017-08-31 4/A CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale -9.194 4.245 -68,41 17,50 -160.895 74.288
2017-09-22 2017-08-31 4/A CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -3.000 13.439 -18,25 17,51 -52.530 235.317
2017-09-22 2017-08-31 4/A CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -6.562 16.439 -28,53 17,50 -114.835 287.682
2017-09-22 2017-08-31 4/A CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 18.756 23.001 441,84 0,94 17.724 21.736
2017-09-05 2017-09-01 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -9.930 25.043 -28,39
2017-09-05 2017-09-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -9.930 4.245 -70,05 17,32 -171.988 73.523
2017-09-05 2017-09-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 9.930 14.175 233,92 0,94 9.384 13.395
2017-09-01 2017-08-31 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -18.756 34.973 -34,91
2017-09-01 2017-08-31 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -3.000 4.245 -41,41 17,51 -52.530 74.330
2017-09-01 2017-08-31 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -15.756 7.245 -68,50 17,50 -275.730 126.788
2017-09-01 2017-08-31 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 18.756 23.001 441,84 0,94 17.724 21.736
2017-08-11 2017-08-09 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -4.781 53.729 -8,17
2017-08-11 2017-08-09 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -4.781 4.245 -52,97 15,00 -71.715 63.675
2017-08-11 2017-08-09 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 4.781 9.026 112,63 0,94 4.518 8.530
2017-07-06 2017-07-03 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -4.781 58.510 -7,55
2017-07-06 2017-07-03 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -4.781 4.245 -52,97 15,52 -74.201 65.882
2017-07-06 2017-07-03 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 4.781 9.026 112,63 0,94 4.518 8.530
2017-06-27 2017-06-26 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -4.481 63.291 -6,61
2017-06-27 2017-06-26 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X 4.481 4.245 -1.898,73 15,00 67.215 63.675
2017-06-27 2017-06-26 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 4.481 8.726 105,56 0,94 4.235 8.246
2017-06-06 2017-06-05 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -300 67.772 -0,44
2017-06-06 2017-06-05 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -300 4.245 -6,60 15,00 -4.500 63.675
2017-06-06 2017-06-05 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 300 4.545 7,07 0,94 284 4.295
2017-06-02 2017-05-31 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 2.266 4.245 114,50 8,68 19.665 36.840
2017-05-02 2017-05-01 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -4.781 68.072 -6,56
2017-05-02 2017-05-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -4.781 1.979 -70,72 15,70 -75.062 31.070
2017-05-02 2017-05-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 4.781 6.760 241,59 0,94 4.518 6.388
2017-04-05 2017-04-04 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -4.781 72.853 -6,16
2017-04-05 2017-04-04 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -4.781 1.979 -70,72 17,50 -83.668 34.632
2017-04-05 2017-04-04 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 4.781 6.760 241,59 0,94 4.518 6.388
2017-04-05 2017-04-03 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -4.781 77.634 -5,80
2017-04-05 2017-04-03 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -4.781 1.979 -70,72 16,94 -80.990 33.524
2017-04-05 2017-04-03 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 4.781 6.760 241,59 0,94 4.518 6.388
2017-03-21 2017-03-20 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -14.343 82.415 -14,82
2017-03-21 2017-03-20 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -14.343 1.979 -87,88 19,60 -281.123 38.788
2017-03-21 2017-03-20 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 14.343 16.322 724,76 0,94 13.554 15.424
2017-03-03 2017-03-03 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -14.343 366.961 -3,76
2017-03-03 2017-03-03 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -14.343 1.979 -87,88 15,00 -215.145 29.685
2017-03-03 2017-03-03 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 14.343 16.322 724,76 1,13 16.264 18.508
2017-01-27 2017-01-25 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
A - Award 310.000 310.000
2016-12-01 2016-11-30 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 1.979 1.979 9,10 17.999 17.999
2016-09-28 2016-09-26 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 122.424 122.424
2016-09-28 2016-09-26 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 48.379 48.379
2016-01-25 2016-01-21 4 CTMX CytomX Therapeutics, Inc.
Employee Stock Option (right to buy)
A - Award 225.000 225.000
2015-10-07 3 CTMX CytomX Therapeutics, Inc.
Common Stock
317.474
2015-10-07 3 CTMX CytomX Therapeutics, Inc.
Common Stock
317.474
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)